Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EP4 receptor antagonism and PGE2 in a human headache model
2008-008713-20Phase 2Terminated
- Sponsor
- Dansk Hovedpinecenter
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Headache and migraine comparing BGC20-1531 arm with Placebo arm (2 arms). Primary endpoint: Headache development and severity after PGE2 infusion. Started Feb 2009; status: terminated.
02
Drugs
BGC20-1531
03
Conditions
Headachemigraine
Beyond the preview
Go deeper on 2008-008713-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008713-20.